High prevalence of angle-closure glaucoma in Vogt-Koyanagi-Harada disease

Int Ophthalmol. 2022 Dec;42(12):3913-3921. doi: 10.1007/s10792-022-02412-4. Epub 2022 Jul 5.

Abstract

Purpose: To determine the prevalence, clinical characteristics, and mechanisms of secondary glaucoma in Vogt-Koyanagi-Harada (VKH) disease.

Methods: This retrospective, longitudinal observational study analyzed the demographic data, disease stage, glaucoma development, intraocular pressure, best-corrected visual acuity, lens status, optic nerve, gonioscopy, management, and visual outcomes of VKH disease. Clinical features were used to categorize the stage of VKH disease. VKH eyes were divided into two groups, with or without glaucoma, undergoing further analysis, including statistical analysis.

Results: 305 eyes of 155 patients with VKH disease with a median follow-up of 22 months were included. Secondary glaucoma developed in 67 (22%) eyes, most of which (64.2%) had chronic recurrent VKH at presentation. Angle-closure was present in 55 (82.1%) of glaucoma eyes. Peripheral anterior and posterior synechiae were present in 58 (86.6%) and 51 (76.1%) eyes, respectively. Pupillary block and posterior synechiae resulted in iris bombé in 17 (25.4%) eyes with glaucoma. At the last visit, visual acuity was worse in eyes with glaucoma (p < 0.001).

Conclusion: We found that angle-closure disease is a significant cause of secondary glaucoma in VKH. Eyes with glaucoma were more likely to present in the chronic recurrent stage of the disease.

Keywords: Angle-closure glaucoma; Peripheral anterior synechiae; Posterior synechiae; Secondary glaucoma; Vogt-Koyanagi-Harada disease.

Publication types

  • Observational Study

MeSH terms

  • Glaucoma* / etiology
  • Glaucoma, Angle-Closure* / diagnosis
  • Glaucoma, Angle-Closure* / epidemiology
  • Glaucoma, Angle-Closure* / etiology
  • Humans
  • Prevalence
  • Retrospective Studies
  • Uveomeningoencephalitic Syndrome* / complications
  • Uveomeningoencephalitic Syndrome* / diagnosis
  • Uveomeningoencephalitic Syndrome* / epidemiology